| Literature DB >> 31638588 |
Jean-Marc Giannoli1, Stéphanie Albarede2, Thierry Avellan3, Jean-Pierre Bouilloux4, Régine Cartier5, Richard Cohen6, Nathalie Colard7, Luc Essemilaire8, Jean-Louis Galinier9, Mathieu Kuentz10, Mickaël Paris11, Henri Portugal12, Florian Scherrer13, Jean-Pascal Siest14, Anne Vassault15, Jean-Michel Vialle16.
Abstract
The recommendations that we formulate in this document come from LABAC, SFBC and FAEEQ. They describe the different steps from the initial application of quality controls, based on risk analysis: the changes of reagent batches or internal quality controls (IQC) batches, the course when IQC are not in accordance with references, the choice of external quality evaluation and the interpretation of its results, the comparability of results obtained in several analysers used in the same laboratory. Lastly, measurement uncertainty, robustness of methods and specificities of near-patient biology and rapid tests are described. Note that these recommendations cannot develop all cases that we could find in laboratories. It remains necessary to carry out an objective strategy, supported with documentary evidences.Entities:
Keywords: external quality assessment; internal quality control; risk analysis; uncertainty
Mesh:
Year: 2019 PMID: 31638588 DOI: 10.1684/abc.2019.1481
Source DB: PubMed Journal: Ann Biol Clin (Paris) ISSN: 0003-3898 Impact factor: 0.459